“…According to a number of studies, G894T polymorphism (rs1799983) is associated with the occurrence and severity of myocardial infarction (MI), CAD, and stroke (Hibi et al, 1998;Hingorani et al, 1999;Colombo et al, 2002;Gardemann et al, 2002;McNamara et al, 2003). According to cross-sectional studies, the À786 T=C polymorphism (rs2070744), which reduces promoter activity, is highly associated with a blunted NO bioactivity in vivo (Rios et al, 2005;Rossi et al, 2006). This polymorphism has been associated with coronary spasm, MI, hypertension, and multivessel CAD in different populations (Nakayama et al, 1999Yoshimura et al, 2000;Hirashiki et al, 2003;Rossi et al, 2003aRossi et al, , 2003bCattaruzza et al, 2004).…”